A new blood test could identify early genetic signs of prostate cancer

Researchers from University College London (UCL, UK), have developed a new test using genetic sequencing in order to identify genetic markers of prostate cancer in the blood, termed a prostate cancer 'fingerprint'. The study is published in The Journal of Clinical Investigation and outlines the potential of the test to allow doctors to monitor the spread of cancers and enable improved treatment strategies.“Metastatic prostate cancer – the most dangerous late stage of the disease – can vary substantially in its treatment response and clinical progression,” commented Anjui Wu (UCL Cancer Institute). “We urgently need biomarkers that will help us determine...